The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...
Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator instructions] I would now like to turn the conference over to your host, Mike Czapar, ...
A charity boss whose weight meant he once struggled to put his socks on has hailed the Mounjaro jab as “life-changing” – ...
Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...
Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a ...
Eli Lilly (NYSE:LLY) reported strong Q4 2024 results on Thursday, surpassing Wall Street estimates, driven by a more than twofold increase in sales of its weight loss and diabetes drugs Mounjaro ...
GLP-1 drugs Mounjaro and Zepbound drive a big revenue ... The drugmaker's stock (LLY) rose 0.5% in regular trading on Thursday after the company said it expects to generate an adjusted 2025 ...
With social media's history of hyped-up health trends, does a 'Mounjaro drink' drink deliver ... with your GP or a nutritionist - especially before starting any sort of diet trend.
WEIGHT loss jabs slash alcohol cravings and can curb dangerous binge drinking, new research suggests. The active drug ...
On Today with Claire Byrne, Maura Fay reports on the rollout of Mounjaro in Ireland and speaks to medical experts about issues surrounding access to this medication. Listen back above. The most ...
The General Pharmaceutical Council clampdown means people will no longer be able to get prescriptions for injections of drugs like Wegovy or Mounjaro after ... She says: “Before having surgery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results